PureIMS
PrivateLast Round
Grant
Sep 3, 2025
Total Funding Raised
$4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PureIMS is a clinical-stage pharmaceutical and therapeutic devices company that develops and commercializes inhaled therapies based on its proprietary Cyclops® dry powder inhaler platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PureIMS Comparables
Compare PureIMS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merxin Ltd | 83% | |
| Iconovo AB | 82% | |
| Hovione | 77% |
PureIMS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 3, 2025 | ||||
| VC Round | Apr 3, 2023 | ||||
| Early Funding | Apr 26, 2019 | ||||
| Seed | Oct 12, 2017 |
PureIMS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boost-UP Foundation | VC Round |
| Carduso Capital | VC Round, Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 8, 4x the trailing average.
- Jul 13, 2026
Open roles increased to 4, representing 33% of headcount.
PureIMS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PureIMS's valuation, stock price, and market status.
Is PureIMS a public or private company?
PureIMS is a private company.
What is the current stock price of PureIMS?
PureIMS is a private company with no public stock price. No recent secondary market data is available.
How much is PureIMS worth (valuation)?
Valuation information for PureIMS is not publicly available.
Can I buy PureIMS stock?
PureIMS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PureIMS's last funding round?
PureIMS's most recent funding round was Early Funding on April 3, 2023.
Who are the main investors in PureIMS?
Key investors in PureIMS include Boost-UP Foundation, Carduso Capital.
Will PureIMS IPO soon?
No public IPO plans have been announced for PureIMS.
How can I track PureIMS secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PureIMS's secondary market activity and sign up for updates.